SURVODUTIDE

Sold by case = 10 vials

Survodutide

For Research Use Only. Not for Human or Veterinary Consumption.

Survodutide is a synthetic dual agonist peptide designed to activate both the glucagon-like peptide-1 receptor (GLP-1R) and the glucagon receptor (GCGR). It is used in laboratory research to investigate signaling pathways related to appetite regulation, energy metabolism, and glucose homeostasis. Researchers are studying Survodutide to explore how dual receptor activation may influence metabolic rate, insulin sensitivity, and energy balance in experimental models.

This compound is intended exclusively for qualified laboratory research. Not for therapeutic, diagnostic, or human use.

Mechanism of Action

• • GLP-1 receptor activation: Studied for its effects on insulin signaling pathways, gastrointestinal motility, and appetite regulation in research models.

  • Glucagon receptor activation: Investigated for its role in stimulating energy expenditure and lipid mobilization under experimental conditions.

  • Synergistic dual-agonist profile: Enables researchers to examine combined receptor activation for potential additive effects on metabolic regulation and glucose homeostasis in laboratory studies.